Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …

BW Shiau, WH Hsu, YW Tsai, JY Wu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …

Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders

TH Liu, HY Liao, CC Chang, CC Lai - Frontiers in Pharmacology, 2024 - frontiersin.org
Objectives This study investigated the clinical effectiveness of molnupiravir for treating non-
hospitalized COVID-19 patients with pre-existing psychiatric disorder. Methods This …